Crescent Grove Advisors’s Emerson Electric EMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,516
Closed -$201K 311
2025
Q4
$201K Buy
+1,516
New +$201K 0.02% 290
2025
Q3
Sell
-1,513
Closed -$202K 298
2025
Q2
$202K Buy
+1,513
New +$174K 0.02% 276
2024
Q2
Sell
-4,805
Closed -$545K 286
2024
Q1
$545K Buy
4,805
+2
+0% +$205 0.06% 172
2023
Q4
$467K Sell
4,803
-298
-6% -$27.3K 0.05% 181
2023
Q3
$493K Buy
5,101
+16
+0.3% +$1.52K 0.06% 174
2023
Q2
$460K Sell
5,085
-12
-0.2% -$1.01K 0.05% 179
2023
Q1
$444K Sell
5,097
-384
-7% -$33.6K 0.05% 184
2022
Q4
$526K Buy
5,481
+702
+15% +$63.1K 0.05% 169
2022
Q3
$350K Buy
4,779
+2
+0% +$166 0.04% 193
2022
Q2
$380K Buy
4,777
+2
+0% +$176 0.04% 185
2022
Q1
$468K Sell
4,775
-1,127
-19% -$107K 0.05% 175
2021
Q4
$549K Buy
+5,902
New +$556K 0.05% 159

Other funds holding EMR

Crescent Grove Advisors's EMR Position: Q1 2026 in Review

Crescent Grove Advisors sold out of Emerson Electric (EMR) in Q1 2026, closing a stake of 1,516 shares — an estimated $201K sold.

Crescent Grove Advisors first reported a position in EMR in Q4 2021 and held it in 12 quarters. The position peaked at $549K in Q4 2021. 2,194 funds tracked by Wall St. Rank hold EMR as of Q1 2026.

  • Crescent Grove Advisors reported no remaining Emerson Electric position as of Q1 2026 after selling out during the quarter.
  • Crescent Grove Advisors sold 1,516 Emerson Electric shares in Q1 2026, an estimated $201K.
  • Crescent Grove Advisors first reported a position in Emerson Electric in Q4 2021 and held it in 12 quarters.
  • Crescent Grove Advisors's Emerson Electric position peaked at $549K in Q4 2021.
  • 2,194 funds tracked by Wall St. Rank held Emerson Electric as of Q1 2026.

Based on Crescent Grove Advisors's 13F filing for Q1 2026, filed 6 May 2026.